According to Blueprint Medicines 's latest financial reports the company's current revenue (TTM ) is ยฃ0.34 Billion. In 2023 the company made a revenue of ยฃ0.19 Billion an increase over the revenue in the year 2022 that were of ยฃ0.16 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 (TTM) | ยฃ0.33 B | 72.46% |
2023 | ยฃ0.19 B | 16.06% |
2022 | ยฃ0.16 B | 26.42% |
2021 | ยฃ0.13 B | -77.09% |
2020 | ยฃ0.58 B | 1048.05% |
2019 | ยฃ50.72 M | 44.62% |
2018 | ยฃ35.07 M | 121.24% |
2017 | ยฃ15.85 M | -29.56% |
2016 | ยฃ22.5 M | 192.58% |
2015 | ยฃ7.69 M |